Market Currents
Valeant Pharmaceuticals International (VRX): Q1 EPS of $0.99 may not be comparable to consensus...
-
Thursday, May 3, 2012, 8:34 AM ETValeant Pharmaceuticals International (VRX): Q1 EPS of $0.99 may not be comparable to consensus of $0.96. Revenue of $856M (+51.5% Y/Y). (PR)
Other date
Latest Earnings Articles
